INO-3107 At The Crossroads: FDA Review Drives Inovio's Upside And Risk [Seeking Alpha]
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ:AMEX Investor Relations:
ir.inovio.com/investors/default.aspx
Company Research
Source: Seeking Alpha
The FDA accepted the BLA for INO-3107 but cited insufficient justification for accelerated approval, introducing significant regulatory risk ahead of the October 30 PDUFA date. INO-3107 demonstrated a 50-100% reduction in surgeries for 72% of trial participants, but evidence is limited to Phase 1/2 data, unlike its approved competitor. INO trades at elevated valuation multiples with only 5-7 months of cash runway, making dilution or spending cuts likely if approval is delayed. kitiwan mesinsom/E+ via Getty Images Thesis: Upside depends on INO-3107 outcome As you probably heard, Inovio Pharmaceuticals ( INO ) previously announced that the FDA has accepted its BLA for INO-3107 in adults with recurrent respiratory papillomatosis [RRP]. It's a decent regulatory This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I w
Show less
Read more
Impact Snapshot
Event Time:
INO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INO alerts
High impacting Inovio Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
INO
News
- Market Sentiment Around Loss-Making Inovio Pharmaceuticals, Inc. (NASDAQ:INO) [Yahoo! Finance]Yahoo! Finance
- *CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOGlobeNewswire
- *CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOPR Newswire
- *CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOGlobeNewswire
- Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107 [Seeking Alpha]Seeking Alpha
INO
Earnings
- 11/10/25 - Miss
INO
Sec Filings
- 1/30/26 - Form SCHEDULE
- 1/27/26 - Form 424B5
- 1/27/26 - Form 8-K
- INO's page on the SEC website